An article in the Wall Street Journal caught my eye last week. NICE, the British national health care service's drug regulator, has decided it will not pay for GlaxoSmithKline's new Lupus drug, Benlysta.

What struck me was not NICE's decision but rather the fact, mentioned...

Today's Wall Street Journal editorial about Anthem's individual health insurance rate increases in California proves the point I made in my last post. Anthem is shifting costs from its group insurance plans to its individual insurance holders.

The WSJ editorial is clearly the result of information...

Anthem Blue Cross is raising rates this year on its California individual insurance plans by up to 39%. It's all over the news and Congress is investigating. I'm thrilled at the attention this is getting, but surprised that it was only noticed this year.

Consider the following:...

We recently had a party for a friend who's leaving town for an undetermined amount of time. She's a freelance writer/journalist/screenwriter who's done very well for herself, until the last year and a half or so.

These past 18 months have been difficult for her. She's done some writing, but...

California offers excellent, and reasonably priced, insurance coverage for people transitioning to freelance work. It's available regardless of pre-existing conditions. Unfortunately, most of those that could benefit have never heard about it. This insurance is available because of a federal mandate in HIPAA legislation - and California's very effective compliance....